No Data
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing
Vir Biotechnology Names Jason O'Byrne Finance Chief
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Caribou Biosciences Announces CFO Resignation and Succession Plan
Express News | Caribou Biosciences- Plans to Appoint Ryan Fischesser to Assume Role of Principal Accounting Officer, Effective as Close of Business on Sept 27
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
